MyFinsight
Home
Blog
About
Protagenic Therapeutics, Inc. new (PTIXW)
Protagenic Therapeutics, Inc. new (PTIXW)
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Balance Sheets Overview
Current Ratio
29.46%
Quick Ratio
29.44%
Debt to Asset Ratio
193.96%
Unit: Dollar
Assets Breakdown
Cash in bank
Prepaid expenses
Vat receivable
Inventories
Liabilities Breakdown
Accumulated deficit
Additional paid in capital
Derivative liabilities
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Balance Sheets
2025-09-30
Cash in bank
2,722,451
Prepaid expenses
90,643
Vat receivable
44,043
Inventories
1,075
Total current assets
2,858,212
Fixed assets, net
51,407
Intangible assets, net
2,093,228
Total long-term assets
2,144,635
Total assets
5,002,847
Notes payable, net
3,156,052
Derivative liabilities
3,656,394
Loans payable, related parties
841,548
Accounts payable
1,641,443
Accrued liabilities
407,975
Total current liabilities
9,703,412
Total liabilities
9,703,412
Preferred stock, value
0
Preferred stock, value-Preferred Stock
0
Preferred stock, value-Series BConvertible Preferred Stock
0
Preferred stock, value-Series CConvertible Preferred Stock
0
Preferred stock, value-Series DConvertible Preferred Stock
0
Preferred stock, value-Series C1Convertible Preferred Stock
1
Common stock, 0.0001 par value, respectively 100,000,000 authorized 1,934,878 and 5,800,000 shares issued outstanding
195
Additional paid in capital
6,845,036
Foreign currency translation adjustment
-221,172
Accumulated deficit
-11,324,625
Total stockholders deficit
-4,700,565
Total liabilities and stockholders deficit
5,002,847
Page 1
Unit: Dollar. Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Balance Sheets
Cash in bank
$2,722,451
Prepaid expenses
$90,643
Vat receivable
$44,043
Inventories
$1,075
Intangible assets, net
$2,093,228
Fixed assets, net
$51,407
Total current assets
$2,858,212
Total long-term
assets
$2,144,635
Total assets
$5,002,847
Accumulated deficit
-$11,324,625
Foreign currency
translation adjustment
-$221,172
Total liabilities and
stockholders deficit
$5,002,847
Total stockholders
deficit
-$4,700,565
Additional paid in capital
$6,845,036
Common stock, 0.0001
par value,...
$195
Preferred stock,
value-Series C1Convertible...
$1
Total liabilities
$9,703,412
Total current
liabilities
$9,703,412
Derivative liabilities
$3,656,394
Notes payable, net
$3,156,052
Accounts payable
$1,641,443
Loans payable,
related parties
$841,548
Accrued liabilities
$407,975
Buy us a coffee